Clinical Trial Details

Trial ID: L0484
Source ID: NCT03783195
Associated Drug: Fructose
Title: Genetic-specific Effects of Fructose on Liver Lipogenesis
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: NAFLD;Non-Alcoholic Fatty Liver Disease
Interventions: Other: Sugar drink
Outcome Measures: Percent change in liver fat content from baseline to week 3;Percent change from baseline in very low density lipoprotein-triglycerides (VLDL-TG) production rate.Percent change from baseline to week 3 in serum concentrations of triglycerides;Percent change from baseline to week 3 in serum concentrations of HDL cholesterol;Percent change from baseline to week 3 in serum concentrations of LDL cholesterol;percent change from baseline to week 3 in serum concentrations of total cholesterol;Percent change from baseline to week 3 in serum concentrations of uric acid;Percent change from baseline to week 3 in serum concentrations of liver function marker (Alanine transaminase- ALT).;Percent change from baseline to week 3 in serum concentrations of liver function marker (Aspartate transaminase-AST).;Percent change from baseline to week 3 in serum concentrations of liver function marker (Alkaline phosphatase-ALP);Percent change from baseline to week 3 in serum concentrations of liver function marker (Gamma glutamyl transpeptidase-GGT)
Sponsor/Collaborators: University of North Carolina, Chapel Hill
Gender: All
Age: 12 Years40 Years
Phases: Not applicable
Enrollment: 48
Study Type: Interventional
Study Designs: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Start Date: 17/12/2018
Completion Date: --
Results First Posted: --
Last Update Posted: 12 December 2020
Locations: United States
URL: https://clinicaltrials.gov/show/NCT03783195